AcquisitionOther
Denali Capital Acquisition Corp. acquired Semnur, the SPAC
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Denali Capital Acquisition Corp. -> Semnur, the SPAC · $2.5 billion
● The proposed business combination would create a publicly traded biopharma company and further provide investment into Semnur for the development of a non-opioid product, SP-102 (10 mg injectable dexamethasone sodium phosphate viscous gel), or SEMDEXA™
Open source record (SEC) ↗